Royalty Pharma PLC
(FRA:RPD)
€
47.47
+0.17 (+0.35%)
Market Cap: 21.95 Bil
Enterprise Value: 31.25 Bil
PE Ratio: 31.34
PB Ratio: 3.62
GF Score: 70/100 Royalty Pharma PLC at TD Cowen Healthcare Conference Transcript
Mar 03, 2026 / 06:10PM GMT
Release Date Price:
€39.57
(+2.06%)
Michael Nedelcovych
Cowen and Company LLC - Equity Analyst
Welcome, everyone. Thanks for joining us. My name is Mike Nedelcovych. I'm part of TD Cowen's Pharmaceuticals Research team, and I'm very pleased to be joined by top management from Royalty Pharma, Terry Coyne, who is EVP and CFO; and Marshall Urist, who is an EVP and the Head of Research and Investments. Thank you for joining us.
Terrance Coyne
Royalty Pharma PLC - Chief Financial Officer
Thanks, Mike.
Marshall Urist
Royalty Pharma PLC - Head of Research & Investments
Thanks for having us.
Questions & Answers
Michael Nedelcovych
Cowen and Company LLC - Equity Analyst
So Royalty Pharma has a phenomenal portfolio. There's a ton to talk about. I actually want to start though with an announcement you made recently vis-a-vis your ambitions in China and Asia more broadly. You hired a Head of Asia.
It seemed like an impressive hire and quite the coup. Maybe you could tell us a little bit
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot